Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
rates decrease » rate decreased (Expand Search), greater decrease (Expand Search), ratio decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
rates decrease » rate decreased (Expand Search), greater decrease (Expand Search), ratio decreased (Expand Search)
-
3521
-
3522
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
3523
-
3524
-
3525
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
3526
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
3527
-
3528
-
3529
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
3530
-
3531
-
3532
-
3533
-
3534
-
3535
-
3536
-
3537
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: -
3538
-
3539
-
3540
Characteristics and outcomes from clams with MarBTN and control healthy clams.
Published 2025Subjects: